Skip to Content

Join the 'Kovanaze' group to help and get support from people like you.

Kovanaze News

St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry

Posted 1 Aug 2016 by Drugs.com

FORT COLLINS, Colo., July 12, 2016 /PRNewswire/ – St. Renatus, LLC, a privately held company based in Fort Collins, Colorado, is pleased to announce it received U.S. Food and Drug Administration (FDA) approval on June 29, 2016 for its first product, a new dental anesthetic, Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray. This is the first product that allows for dental anesthesia to be administered through a nasal spray without using a needle. "For more than 100 years, the dental industry has delivered dental anesthesia using a needle injection. Now, through the efforts of a dedicated team, we have developed a revolutionary needle-free method for delivering pulpal anesthesia," said Steve Merrick, St. Renatus' CEO. Kovanaze is intended for use in dentistry as a topical anesthetic, delivered in the nasal cavity to achieve pulpal (tooth nerve) anesthesia for the ... Read more

Related support groups: Local Anesthesia, Kovanaze, Oxymetazoline/tetracaine

Ask a Question

Further Information

Related Condition Support Groups

Local Anesthesia

Kovanaze Patient Information at Drugs.com